Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.
What’s Going On With ImmunoPrecise Antibodies Stock Wednesday?
Where Today's News Shapes Tomorrow
February 16, 2026
Headlines
